Repro Med Systems (KRMD) Tops Q4 EPS by 1c ; Offers Guidance

Repro Med Systems (NASDAQ: KRMD) reported Q4 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $8.8 million versus the consensus estimate of $8.13 million.

GUIDANCE:

Repro Med Systems sees FY2025 revenue of $38-39 million, versus the consensus of $38.39 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15